UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-03, Vol.22 (2), p.e101-e103

2016

Volltextzugriff (PDF)

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Arteriosclerosis, thrombosis, and vascular biology, 2002-05, Vol.22 (5), p.867-873

2002

Volltextzugriff (PDF)

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Circulation (New York, N.Y.), 1997-08, Vol.96 (3), p.761-768

1997

Volltextzugriff (PDF)

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort

Arteriosclerosis, thrombosis, and vascular biology, 1998-01, Vol.18 (1), p.84-91

1998

Volltextzugriff (PDF)

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers

Arteriosclerosis, thrombosis, and vascular biology, 2000-05, Vol.20 (5), p.1387-1391

2000

Volltextzugriff (PDF)

Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers

Thrombosis and haemostasis, 2001-06, Vol.85 (6), p.999-1003

2001

Volltextzugriff (PDF)

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles‐NImes prediction model

Journal of thrombosis and haemostasis, 2014-02, Vol.12 (2), p.138-146

2014

Volltextzugriff (PDF)

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

Journal of thrombosis and haemostasis, 2003-04, Vol.1 (4), p.791-797

2003

Volltextzugriff (PDF)

The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

Journal of thrombosis and haemostasis, 2003-11, Vol.1 (11), p.2322-2329

2003

Volltextzugriff (PDF)

Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses

Thrombosis and haemostasis, 2001-05, Vol.85 (5), p.800-805

2001

Volltextzugriff (PDF)

Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples

International Journal of Laboratory Hematology, 2017-06, Vol.39 (3), p.279-285

2017

Volltextzugriff (PDF)

Facteur V : proaccélérine

EMC - Biologie médicale, 2012-03, Vol.7 (1), p.1-4

Aillaud, M.-F.

2012

Volltextzugriff (PDF)

Facteur VII : proconvertine

EMC - Biologie médicale, 2012-03, Vol.7 (1), p.1-4

Aillaud, M.-F.

2012

Volltextzugriff (PDF)

Facteur II : prothrombine

EMC - Biologie médicale, 2012-03, Vol.7 (1), p.1-4

Aillaud, M.-F.

2012

Volltextzugriff (PDF)

Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway

Thrombosis and haemostasis, 1996-04, Vol.75 (4), p.562-566

1996

Volltextzugriff (PDF)

The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay

Haemophilia : the official journal of the World Federation of Hemophilia, 2011-09, Vol.17 (5), p.e958-e962

2011

Volltextzugriff (PDF)

Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?

International journal of laboratory hematology, 2015-02, Vol.37 (1), p.125-132

2015

Volltextzugriff (PDF)

Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis

Kidney international, 1995-09, Vol.48 (3), p.794-800

1995

Volltextzugriff (PDF)

Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis

Thrombosis and haemostasis, 1987-02, Vol.57 (1), p.67-72

1987

Volltextzugriff (PDF)

Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study

Thrombosis and haemostasis, 2004-11, Vol.92 (5), p.1122-1128

2004

Volltextzugriff (PDF)

ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden

Thrombosis and haemostasis, 2000-04, Vol.83 (4), p.630-631

2000

Volltextzugriff (PDF)

Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers

Thrombosis and haemostasis, 2001-12, Vol.86 (6), p.1583-1584

2001

Volltextzugriff (PDF)

Évaluation d'un test fonctionnel dans le dépistage des déficits en protéine S

Annales de biologie clinique (Paris), 2003-09, Vol.61 (5), p.597-601

2003

Volltextzugriff (PDF)

Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation

Journal of thrombosis and haemostasis, 2008-11, Vol.6 (11), p.1975-1977

2008

Volltextzugriff (PDF)

Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients

Thrombosis and haemostasis, 2000-01, Vol.83 (1), p.46-48

2000

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(75)

Publikationsform

Artikel
(162)
Berichte
(10)

Sprache

Englisch
(112)
Französisch
(60)

Erscheinungsjahr

n.n

Thema

Humans
(107)
Science & Technology
(80)
Life Sciences & Biomedicine
(78)
Male
(68)
Female
(59)
Adult
(52)
Hematology
(52)
Middle Aged
(51)
Biological And Medical Sciences
(46)
Cardiovascular System & Cardiology
(44)
Medical Sciences
(44)
Peripheral Vascular Disease
(43)
Aged
(26)
Adolescent
(17)
Risk Factors
(14)
Fibrinolysis
(13)
Sciences Biologiques Et Medicales
(12)
Sciences Medicales
(12)
Factor V - Genetics
(10)
Hematologic And Hematopoietic Diseases
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Discrepancies between one stage assay and chromogenic substrate assay in patients treated with recombinant or plasma-derived FVIII and usefulness of a specific standard in ReFacto AF®-treated patients

Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex relationship to elevated TPA antigen in patients with high PAI-1 activity levels

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort

The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers

Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers

Risk assessment of venous thrombosis in families with known hereditary thrombophilia: the MARseilles‐NImes prediction model

Weak and non‐independent association between plasma TAFI antigen levels and the insulin resistance syndrome

The plasminogen activator inhibitor‐1 −675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH Study

Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses

Agreement between factor XIII activity and antigen assays in measurement of factor XIII: A French multicenter study of 147 human plasma samples

Facteur V : proaccélérine

Facteur VII : proconvertine

Facteur II : prothrombine

Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway

The use of the new ReFacto AF Laboratory Standard allows reliable measurement of FVIII:C levels in ReFacto AF mock plasma samples by a one-stage clotting assay

Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?

Antiphospholipids in hemodialysis patients: Relationship between lupus anticoagulant and thrombosis

Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis

Effect of Interleukin-6 promoter polymorphisms in survivors of myocardial infarction and matched controls in the North and South of Europe. The HIFMECH Study

ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V Leiden

Ala147Thr and C+1542G polymorphisms in the TAFI gene are not asssociated with a higher risk of venous thrombosis in FV Leiden carriers

Évaluation d'un test fonctionnel dans le dépistage des déficits en protéine S

Relation between the antithrombin Cambridge II mutation, the risk of venous thrombosis, and the endogenous thrombin generation

Fluvastatin decreases soluble thrombomodulin in cardiac transplant recipients

Suchergebnisse filtern